Briacell Therapeutics Corp Stock Toronto S.E.
Equities
CA10778Y1043
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 33.57M 45.92M |
---|---|---|---|---|---|
Net income 2024 * | -24M -32.83M | Net income 2025 * | -28M -38.31M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.51
x | P/E ratio 2025 * |
-1.68
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.73% |
Managers | Title | Age | Since |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 16-10-31 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 16-01-31 |
Chief Tech/Sci/R&D Officer | 53 | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 16-05-09 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-08-30 |
Rebecca Taub
BRD | Director/Board Member | 71 | 18-03-06 |
1st Jan change | Capi. | |
---|---|---|
-1.31% | 104B | |
+6.94% | 97.47B | |
+5.71% | 22.25B | |
-13.24% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.96% | 16.36B | |
+8.08% | 14.39B | |
+37.74% | 12.37B |